Changes in COPD Treatment Strategy: Guidance for Appropriate Utilization
Recorded on November 28, 2017
Sponsored by Boehringer-Ingelheim
The chronic obstructive pulmonary disease (COPD) landscape is evolving rapidly; new treatments and revised guidelines, coupled with a growing population, can make for complicated decisions in managed markets.
In this presentation, a distinguished pulmonologist and a pharmacy professional with deep payer experience combine their expertise to explore the paradigm shift in the treatment for COPD to help you navigate management for your population.
The presentation will examine:
- Clinical evidence supporting the changes to the 2017 GOLD Report
- Economic perspective on COPD treatment options
- Options to advance appropriate utilization
- Sanjay Sethi, MD
Assistant Vice President for Health Sciences and Medical Director of the University of Buffalo Clinical Research Office
Professor of Medicine, Chief of the Division of Pulmonary, Critical Care and Sleep Medicine
- Andrew Cournoyer, RPh, MBA
Vice President, Formulary Access Solutions for Precision for Value
Former Senior Director of Formulary and Utilization Management
This webinar is sponsored, developed and presented by the sponsor. The content of the Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of the Academy of Managed Care Pharmacy.